Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1997 Jun;43(6):659–660. doi: 10.1046/j.1365-2125.1997.00596.x

Association between CYP2C19 genotype and proguanil oxidative polymorphism

J K Coller 1, A A Somogyi 1, F Bochner 1
PMCID: PMC2042790  PMID: 9205829

Abstract

Aims To examine the relationship between proguanil metabolism and the number of mutations in CYP2C19 by comparing the CYP2C19 genotype and proguanil phenotype of 10 subjects.

Methods Partial clearance and urinary metabolic ratio data were obtained from a previous study of 10 subjects [ 5]. Analysis of CYP2C19 genotypes was performed using PCR amplification followed by restriction endonuclease digestion of genomic DNA from a blood sample.

Results The intrinsic partial clearance of PG to CG ranged from 0.41–10.1l h−1, and was related to the number of functional CYP2C19 alleles present. Genotypic PMs had metabolic ratios >13, while genotypic heterozygote EMs had metabolic ratios <9.

Conclusions Proguanil may be a suitable phenotyping probe for the CYP2C19 genetic polymorphism, however the exact antimode of the urinary metabolic ratio chosen to separate poor and extensive metabolisers needs further investigation.

Keywords: proguanil, metabolic ratio, intrinsic clearance, CYP2C19, mutant alleles

Full Text

The Full Text of this article is available as a PDF (267.2 KB).


Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES